|
End-of-day quote
New Zealand S.E.
21/10/2026
|
5-day change | 1st Jan Change | ||
| 4.580 NZD | -0.22% |
|
+2.00% | +35.50% |
| 06/10 | ASX Preview: Australian Shares to Rise as Oil Prices Fall; Tower Lifts Fiscal 2026 Profit Guidance | MT |
| 06/10 | AFT Pharmaceuticals on Track for Fiscal 2027 Revenue, Profit Targets | MT |
| Market Cap | 48Cr 27Cr 24Cr 23Cr 20Cr 38Cr 2.58TCr 39Cr 270.31Cr 106.06Cr 1.36TCr 102.51Cr 100.38Cr 4.32TCr | P/E 2027 * |
24.4x | P/E 2028 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 51Cr 29Cr 26Cr 24Cr 22Cr 41Cr 2.74TCr 41Cr 287.1Cr 112.65Cr 1.44TCr 108.88Cr 106.61Cr 4.59TCr | EV / Sales 2027 * |
1.68x | EV / Sales 2028 * | 1.46x |
| Free-Float |
22.37% | Yield 2027 * |
0.72% | Yield 2028 * | 0.91% |
| Markets | Quality | ||
|---|---|---|---|
New Zealand S.E.
| AFT | End-of-day quote | |
Australian S.E.
| AFP | Delayed |
Last Transcript: AFT Pharmaceuticals Limited
| 20/24/20 | Rentevrees zet Bel20 onder druk | |
| 19/24/19 | KBC uitblinker op groene beurs | |
| 19/24/19 | Brusselse beurs opent flink hoger | |
| 19/24/19 | Brussel start handelsdag vermoedelijk in het groen | |
| 19/24/19 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | -0.22% | ||
| 1 week | +2.00% | ||
| Current month | +6.51% | ||
| 1 month | +7.01% | ||
| 3 months | +16.24% | ||
| 6 months | +27.93% | ||
| Current year | +35.50% |
| 1 week | 4.4 |  | 4.59 |
| 1 month | 4.21 | | 4.64 |
| Current year | 3.35 | | 4.85 |
| 1 year | 3 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 04/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 04/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 22/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 04/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 04/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/07/25 | Buy | Founder | 2,00,000 | 0.1907% | ||
| 26/06/25 | Free | Founder | 17,755 | 0.0169% | ||
| 02/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +2.00% | +50.16% | +34.71% | 27Cr | |
| +2.18% | +3.07% | +58.79% | +123.72% | 1,13300Cr | |
| +1.95% | +3.12% | +35.38% | +72.53% | 62TCr | |
| -0.61% | -0.03% | +23.89% | +95.76% | 50TCr | |
| -0.56% | +2.24% | +38.40% | +63.42% | 38TCr | |
| +1.68% | +4.35% | +72.93% | +46.59% | 37TCr | |
| +1.11% | +1.57% | +21.95% | +51.34% | 29TCr | |
| +1.39% | +0.44% | +1.71% | +26.28% | 26TCr | |
| +1.51% | +1.86% | +49.36% | +61.90% | 24TCr | |
| +1.06% | -1.77% | +27.27% | +99.30% | 19TCr | |
| Average | +0.97% | +3.30% | +37.98% | +67.55% | 39.88TCr | |
| Weighted average by Cap. | +1.27% | +3.73% | +41.60% | +82.78% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 30Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.63TCr 25Cr 170.98Cr 67Cr 857.38Cr 65Cr 63Cr 2.73TCr | 35Cr 20Cr 18Cr 16Cr 15Cr 28Cr 1.85TCr 28Cr 194.29Cr 76Cr 974.29Cr 74Cr 72Cr 3.1TCr |
| Net income | 1.97Cr 1.12Cr 99.85L 92.44L 83.66L 1.58Cr 105.74Cr 1.59Cr 11Cr 4.35Cr 56Cr 4.2Cr 4.12Cr 177.11Cr | 2.48Cr 1.41Cr 1.26Cr 1.16Cr 1.05Cr 1.99Cr 133.22Cr 2.01Cr 14Cr 5.48Cr 70Cr 5.3Cr 5.19Cr 223.13Cr |
| Net Debt | 2.98Cr 1.7Cr 1.51Cr 1.4Cr 1.27Cr 2.39Cr 160.18Cr 2.42Cr 17Cr 6.59Cr 84Cr 6.37Cr 6.23Cr 268.3Cr | 2.46Cr 1.4Cr 1.25Cr 1.15Cr 1.04Cr 1.97Cr 132.05Cr 1.99Cr 14Cr 5.43Cr 69Cr 5.25Cr 5.14Cr 221.19Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | NZ$4.580 | -0.22% | 10,656 |
| 20/26/20 | NZ$4.590 | +2.23% | 71,478 |
| 19/26/19 | NZ$4.490 | +0.90% | 16,236 |
| 16/26/16 | NZ$4.450 | +1.14% | 9,398 |
| 15/26/15 | NZ$4.400 | -2.00% | 14,508 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
